Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
19,579 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00024362 | BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00024388 | Chemotherapy in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00024401 |
| DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer |
| unknown |
| Phase 2 |
| — |
| TheradexINDUSTRY |
| 1 |
| Jul 24, 2008 |
| clinicaltrials |
| NCT00024414 | DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00039156 | BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma | unknown | Phase 2 | — | TheradexINDUSTRY | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00039169 | BAY 59-8862 in Treating Patients With Advanced Kidney Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00056693 | Treatment With SU11248 in Patients With Neuroendocrine Tumors | completed | Phase 2 | 107 | PfizerINDUSTRY | 1 | Jul 21, 2008 | clinicaltrials |
| NCT00222469 | Combination Chemotherapy for 1st Line Treatment of Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 50 | University of OklahomaOTHER | 1 | Jul 9, 2008 | clinicaltrials |
| NCT00093002 | Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer | completed | Phase 2 | 179 | AstraZenecaINDUSTRY | 6 | Jun 12, 2008 | clinicaltrials |
| NCT00589212 | GliaSite 1-3 Mets Study | completed | Phase 2 | 50 | Hologic, Inc.INDUSTRY | 1 | Jun 11, 2008 | clinicaltrials |
| NCT00017680 | Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis | completed | Phase 2 | 25 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jun 9, 2008 | clinicaltrials |
| NCT00386087 | Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy | completed | Phase 2 | 41 | Eli Lilly and CompanyINDUSTRY | 1 | Jun 6, 2008 | clinicaltrials |
| NCT00690703 | Radiofrequency Ablation of Pulmonary Tumors Response Evaluation(RAPTURE) | completed | Phase 2 | 106 | Angiodynamics, Inc.INDUSTRY | 5 | Jun 5, 2008 | clinicaltrials |
| NCT00139243 | Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00187031 | A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor | completed | Phase 2 | 37 | St. Jude Children's Research HospitalOTHER | 2 | Jun 4, 2008 | clinicaltrials |
| NCT00187161 | Treatment of Burkitt Lymphoma/Leukemia and B Large Cell NHL | completed | Phase 2 | 68 | St. Jude Children's Research HospitalOTHER | 1 | Jun 4, 2008 | clinicaltrials |
| NCT00135135 | Therapy for Children With Neuroblastoma | completed | Phase 2 | 23 | St. Jude Children's Research HospitalOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00139230 | Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck | completed | Phase 2 | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jun 3, 2008 | clinicaltrials |
| NCT00159094 | A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer | unknown | Phase 2 | 30 | Hematology Oncology ConsultantsOTHER | 1 | Jun 2, 2008 | clinicaltrials |
| NCT00177554 | Phase II Trial of CHOP-R Followed by Zevalin and Rituxan in Follicular Lymphoma | completed | Phase 2 | 60 | University of PittsburghOTHER | 1 | May 29, 2008 | clinicaltrials |
| NCT00284817 | Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | 17 | MedImmune LLCINDUSTRY | 1 | May 29, 2008 | clinicaltrials |
| NCT00685204 | An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma(TL139) | unknown | Phase 2 | 90 | Taxolog Inc.INDUSTRY | 1 | May 28, 2008 | clinicaltrials |
| NCT00217282 | Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 45 | Mt. Sinai Medical Center, MiamiOTHER | 1 | May 22, 2008 | clinicaltrials |
| NCT00675870 | Study of NRX 195183 Therapy for Patients With Relapsed or Refractory Acute Promyelocytic Leukemia | unknown | Phase 2 | 65 | NuRx Pharmaceuticals, Inc.INDUSTRY | 1 | May 12, 2008 | clinicaltrials |
| NCT00441818 | Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma | unknown | Phase 1 / Phase 2 | 59 | TanoxINDUSTRY | 1 | May 9, 2008 | clinicaltrials |
| NCT00443573 | Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer | suspended | Phase 1 / Phase 2 | 100 | ARCA Biopharma, Inc.INDUSTRY | 1 | May 7, 2008 | clinicaltrials |
| NCT00176813 | Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer | completed | Phase 2 | 5 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 6, 2008 | clinicaltrials |
| NCT00087854 | Study of Individualized Amonafide to Treat Prostate Cancer | completed | Phase 1 / Phase 2 | 40 | Xanthus Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 23, 2008 | clinicaltrials |
| NCT00064857 | Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors | completed | Phase 2 | 26 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Apr 22, 2008 | clinicaltrials |
| NCT00250861 | Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma | terminated | Phase 2 | 110 | US Oncology ResearchINDUSTRY | 1 | Apr 21, 2008 | clinicaltrials |
| NCT00095186 | Safety/Efficacy Study of Oral Recombinant Human Lactoferrin in Renal Cell Carcinoma | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Apr 10, 2008 | clinicaltrials |
| NCT00187109 | Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy | completed | Phase 1 / Phase 2 | 40 | St. Jude Children's Research HospitalOTHER | 1 | Apr 10, 2008 | clinicaltrials |
| NCT00108290 | Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer | completed | Phase 2 | — | US Department of Veterans AffairsFED | 1 | Apr 4, 2008 | clinicaltrials |
| NCT00116363 | Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma | unknown | Phase 2 | 25 | Introgen TherapeuticsINDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00286247 | Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer | completed | Phase 2 | 60 | Introgen TherapeuticsINDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00384124 | Topical Imiquimod for Bowen's Disease of the Head and Neck | unknown | Phase 2 / Phase 3 | 50 | Brooke Army Medical CenterFED | 1 | Mar 26, 2008 | clinicaltrials |
| NCT00510471 | Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma | terminated | Phase 2 | — | Genitope CorporationINDUSTRY | 1 | Mar 18, 2008 | clinicaltrials |
| NCT00059735 | A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma | completed | Phase 2 | 30 | Eisai Inc.INDUSTRY | 2 | Mar 5, 2008 | clinicaltrials |
| NCT00001165 | Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas | completed | Phase 2 | 999 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001188 | The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001189 | The Treatment of Grade I Sarcomas and Benign, Non-Metastasizing Highly Invasive Soft Tissue Tumors | completed | Phase 2 | 150 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001193 | A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer | completed | Phase 2 | 200 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001237 | Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas | completed | Phase 2 | 120 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001239 | Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001250 | Effect of Preoperative Chemotherapy on Axillary Lymph Node Metastases in Stage II Breast Cancer: A Prospective Randomized Trial | completed | Phase 2 | 130 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001266 | A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinoma | completed | Phase 2 | 70 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001335 | New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma | completed | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001339 | A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001427 | A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials